Your session is about to expire
← Back to Search
Exercise for Parkinson's Disease
Phase 1 & 2
Waitlist Available
Led By James F Morley, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This study is evaluating whether exercise can slow the progression of Parkinson's disease.
Eligible Conditions
- Parkinson's Disease
- Parkinsonism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
change in dopamine transporter imaging
Trial Design
2Treatment groups
Active Control
Group I: ExerciseActive Control1 Intervention
aerobic walking
Group II: No exerciseActive Control1 Intervention
normal activity
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,483 Total Patients Enrolled
University of PennsylvaniaOTHER
2,000 Previous Clinical Trials
42,879,968 Total Patients Enrolled
James F Morley, MDPrincipal InvestigatorCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger